Table 1.
Sociodemographic and clinical characteristics of the study sample (N = 576)
| Characteristic | |
|---|---|
| Mean (SD) age at biopsy, years (n = 576; missing: 0) | 66 (10) |
| Median PSA (ng/ml) (IQR) (n = 576; missing: 0) | 7 (5–10) |
| No. max. PI-RADS Score (%) (n = 576; missing: 0) | |
| ≤ 3 | 146 (25) |
| 4 | 298 (52) |
| 5 | 132 (23) |
| No. DRE (%) (n = 505; missing: 71) | |
| Suspicious | 147 (29) |
| Not suspicious | 358 (71) |
| Median prostate volume, ml (IQR) (n = 506; missing: 70) | 45 (35–60) |
| No. prior biopsy (%) (n = 576; missing: 0) | |
| Yes (negative) | 73 (13) |
| Yes (positive/active surveillance) | 9 (2) |
| No | 494 (85) |
| Median number of MRI lesions (Min–Max) (n = 576; missing: 0) | 1 (1–4) |
| Mean (SD) number of total cores extracted (n = 576; missing: 0) | 15 (2) |
| Mean (SD) number of fusion cores extracted (n = 576; missing: 0) | 4 (2) |
| No. patients with prostate cancer (%) (n = 576; missing: 0) | |
| Yes | 413 (72) |
| No | 163 (28) |
| No. tumor grading (%) (n = 413; missing: 0) | |
| ISUP 1 | 40 (7) |
| ISUP 2 | 185 (32) |
| ISUP 3 | 100 (17) |
| ISUP 4 | 64 (11) |
| ISUP 5 | 24 (4) |
DRE digital rectal examination, IQR inter quartile range, ISUP International Society of Urological Pathology, Min–Max minimum–maximum, No. number, PSA prostate specific antigen, SD standard deviation